This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ: Health Care

Insider Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Net Insider Transaction 245,095 215,352 -34,478 59,403 238,763 328,835 168,567
Shares Bought 247,095 265,654 218,683 409,141 552,706 559,551 304,706
Shares Sold 2,000 50,302 253,161 349,738 313,943 230,716 136,139
Institutional Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Total Shares Held 94.99M 98.49M 99.20M 99.40M 98.50M 96.28M 97.43M
Shares Bought 11.56M 11.73M 13.28M 13.49M 11.73M 5.01M 6.00M
Shares Sold 5.63M 5.89M 4.24M 4.33M 5.88M 6.28M 5.03M
REGN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

REGN Regeneron Pharmaceuticals Inc

Chart of REGN

Analysts Ratings for REGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 8 7 8
Moderate Buy 2 2 2 2
Hold 10 9 9 7
Moderate Sell 0 0 0 0
Strong Sell 2 2 1 2
GET REGN ANALYST REPORT

REGN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs